PEPG
PEPG clinical trials: PepGen Inc.
Every trial on ClinicalTrials.gov where PepGen Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 5
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PEPG on the catalyst calendar · PEPG registry changes
- Primary completion Mar 2027Sponsor estimatePhase 2NCT06667453A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1PepGen Inc · Myotonic Dystrophy 1RecruitingPEPGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2029Sponsor estimatePhase 2NCT07220603An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)PepGen Inc · Myotonic Dystrophy 1RecruitingPEPGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 28, 2025ActualPhase 1NCT06204809Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1PepGen Inc · Myotonic Dystrophy 1CompletedPEPGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 28, 2025ActualPhase 2NCT06079736A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping TreatmentPepGen Inc · Duchenne Muscular DystrophyTerminatedPEPGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 28, 2025ActualPhase 2NCT06833931A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping TreatmentPepGen Inc · Duchenne Muscular Dystrophy (DMD)WithdrawnPEPGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner